PureTech Health (PRTC) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 May 2022 07:00 AM
RNS
Transaction in Own Shares
23 May 2022 07:00 AM
RNS
Transaction in Own Shares
20 May 2022 07:00 AM
RNS
Transaction in Own Shares
19 May 2022 07:00 AM
RNS
PDMR Notification RSU Vesting
19 May 2022 07:00 AM
RNS
Transaction in Own Shares
18 May 2022 07:00 AM
RNS
Transaction in Own Shares
17 May 2022 12:00 PM
RNS
PRTC to Present at UBS Healthcare Conference
17 May 2022 07:00 AM
RNS
Transaction in Own Shares
16 May 2022 02:30 PM
RNS
PRTC Presents LYT-100 Data at ATS Conference
16 May 2022 07:00 AM
RNS
Transaction in Own Shares
13 May 2022 07:00 AM
RNS
Transaction in Own Shares
12 May 2022 07:00 AM
RNS
Transaction in Own Shares
11 May 2022 07:00 AM
RNS
Transaction in Own Shares
10 May 2022 07:00 AM
RNS
Transaction in Own Shares
09 May 2022 07:00 AM
RNS
PRTC Share Buyback Programme Commences Purchases
05 May 2022 07:00 AM
RNS
PRTC Announces Share Buyback Programme Up to $50M
04 May 2022 11:35 AM
RNS
Gelesis Presents GS200 Weight Loss Data at ECO
03 May 2022 07:00 AM
RNS
Total Voting Rights
29 Apr 2022 11:05 AM
RNS
Gelesis Data: Therapeutic Shows Gut Health Benefit
26 Apr 2022 07:00 AM
RNS
PRTC Final Results & Publication of Annual Report
13 Apr 2022 04:44 PM
RNS
PRTC's Vedanta Publishes VE303 Data
12 Apr 2022 12:05 PM
RNS
Akili Depression Data Published in AJP
12 Apr 2022 07:00 AM
RNS
Glyph: 20x Oral Bioavailability of Buprenorphine
07 Apr 2022 07:00 AM
RNS
Notice of Results
01 Apr 2022 07:00 AM
RNS
Total Voting Rights
24 Mar 2022 07:00 AM
RNS
PRTC Appoints Merck Vet to BOD & Audit Committee
17 Mar 2022 01:05 PM
RNS
Akili Adds Gaming Vet as Chief Product Officer
16 Mar 2022 10:35 AM
RNS
Gelesis: Record-Breaking Plenity Prescriptions
08 Mar 2022 12:05 PM
RNS
Akili Named to World's Most Innovative Companies
18 Feb 2022 04:30 PM
RNS
Holding(s) in Company
17 Feb 2022 12:05 PM
RNS
Akili Data: Enhanced Brain Activity in Kids w/ADHD
15 Feb 2022 07:00 AM
RNS
PRTC's Akili Files Registration Statement on S-4
10 Feb 2022 12:00 PM
RNS
PRTC to Present at Leerink Healthcare Conference
04 Feb 2022 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
31 Jan 2022 11:50 AM
RNS
PRTC's Gelesis Launches Plenity Media Campaign
26 Jan 2022 12:02 PM
RNS
PRTC's Akili to Become Public & $162M Funding
14 Jan 2022 07:00 AM
RNS
PRTC's Gelesis to Debut on NYSE Today Ticker GLS
07 Jan 2022 12:00 PM
RNS
PureTech to Present at JPM Healthcare Conference
06 Jan 2022 07:00 AM
RNS
LYT-100 Shows Improved AE Profile vs Pirfenidone
05 Jan 2022 12:05 PM
RNS
Gelesis Adds to BOD & Declared Effective by SEC
20 Dec 2021 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
16 Dec 2021 07:00 AM
RNS
PRTC Provides Recap Ahead of Catalyst-Rich 2022
08 Dec 2021 12:00 PM
RNS
PRTC Presents Data at ACNP Conference For LYT-300
07 Dec 2021 12:00 PM
RNS
PRTC's Lymphatic Platform Candidate Human Study
01 Dec 2021 12:10 PM
RNS
PRTC: Gelesis' Plenity Now Broadly Available in US
01 Dec 2021 07:00 AM
RNS
Total Voting Rights
18 Nov 2021 12:10 PM
RNS
PRTC's Gelesis Receives $30M Plenity Order from Ro
16 Nov 2021 12:00 PM
RNS
PRTC Publishes Previous LYT-100 MAD Study Results
15 Nov 2021 12:00 PM
RNS
PRTC Presents at Two Upcoming Investor Conferences
12 Nov 2021 12:00 PM
RNS
PRTC Presents Immunooncology Ph 1/2 Trial at SITC

PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange under the ticker PRTC.

PureTech share price launched at 178p in 2015.

UK 100

Latest directors dealings